IHE Rises on GLP-1 Drugs
IHE gains driven by GLP-1 drug sales, IXJ invests for long-term growth
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
IHE gains driven by GLP-1 drug sales, IXJ invests for long-term growth
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.